Dr. Philip M. Arlen to Chair and Present at Cambridge Healthtech Institute Immuno-Oncology Summit 2024, August 7-9, 2024, Philadelphia, PA
Precision Biologics’ CEO, Dr. Philip M. Arlen, to Chair Therapeutic Cancer Vaccine Program, and lead panel discussion; plus Present in the Tumor Microenvironment Program, at the Cambridge Healthtech Institute 12th Annual Immuno-Oncology Summit 2024, August 7-9, 2024, Hilton Philadelphia at Penn’s Landing, Philadelphia, PA, themed “Connecting the Immunotherapy Community to Drive Innovation and Collaboration.”
1) Therapeutic Cancer Vaccines program-
Innovative Vaccine Strategies to Advance Cancer Immunotherapy
Date: Wednesday, August 7
mRNA-BASED CANCER VACCINES
Time: 8:35 am
Chairperson’s Remarks
Philip Arlen, MD, President & CEO, Precision Biologics
Time: 9:40 am
PANEL DISCUSSION:
Progress and Prospects for Cancer Vaccines
PANEL MODERATOR:
Philip Arlen, MD, President & CEO, Precision Biologics
https://www.immuno-oncologysummit.com/
(click on Therapeutic Cancer Vaccine Program to get agenda)
2) Tumor Microenvironment program-
Reshaping the TME to Advance Cancer Immunotherapies
Date: Friday, August 9
Time: 9:35 am
Title: Delving into the Mechanism of Action of Neoantigen Antibodies to Aid the Development of Highly Effective Combination Strategies Towards More Successful Therapies
Philip Arlen, MD, President & CEO, Precision Biologics
https://www.immuno-oncologysummit.com/
(click on Tumor Microenvironment Program for details)